Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


16.09.2019

1 Am J Clin Oncol
2 Ann Oncol
1 Ann Surg Oncol
9 Anticancer Res
1 BMC Cancer
1 Br J Cancer
3 Cancer
1 Cancer Res
1 Clin Cancer Res
2 Eur J Gastroenterol Hepatol
1 Gastroenterology
10 Gastrointest Endosc
5 Int J Cancer
3 Int J Colorectal Dis
1 J Am Coll Surg
3 Oncol Rep
4 PLoS One
2 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. KOUSTAS E, Sarantis P, Theoharis S, Saetta AA, et al
    Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
    Am J Clin Oncol. 2019 Sep 11. doi: 10.1097/COC.0000000000000592.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. NYAMUNDANDA G, Fontana E, Sadanandam A
    Is the tumour microenvironment a critical prognostic factor in early-stage colorectal cancer?
    Ann Oncol. 2019 Aug 29. pii: 5556307. doi: 10.1093.
    PubMed     Text format    

  3. DIENSTMANN R, Villacampa G, Sveen A, Mason MJ, et al
    Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
    Ann Oncol. 2019 Aug 27. pii: 5555302. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. ZHOU X, Yi Y, Liu Z, Cao W, et al
    Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2019;26:1676-1684.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. OHARA T, Mori T
    Antiproliferative Effects of Short-chain Fatty Acids on Human Colorectal Cancer Cells via Gene Expression Inhibition.
    Anticancer Res. 2019;39:4659-4666.
    PubMed     Text format     Abstract available

  6. OSHIRO H, Tome Y, Kiyuna T, Yoon SN, et al
    Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:4667-4671.
    PubMed     Text format     Abstract available

  7. KURAMOCHI H, Nakajima GO, Hayashi K, Araida T, et al
    Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer.
    Anticancer Res. 2019;39:4729-4736.
    PubMed     Text format     Abstract available

  8. HA YJ, Tak KH, Kim SK, Kim CW, et al
    Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
    Anticancer Res. 2019;39:4853-4864.
    PubMed     Text format     Abstract available

  9. YUN CW, Lee JH, Lee SH
    Hypoxia-induced PGC-1alpha Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
    Anticancer Res. 2019;39:4865-4876.
    PubMed     Text format     Abstract available

  10. SEATON ME, Peters U, Johnson KC, Kooperberg C, et al
    Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer.
    Anticancer Res. 2019;39:4877-4884.
    PubMed     Text format     Abstract available

  11. SIGNORELLI C, Chilelli MG, Sperduti I, Giacinti S, et al
    Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
    Anticancer Res. 2019;39:4917-4924.
    PubMed     Text format     Abstract available

  12. DIMBERG J, Shamoun L, Landerholm K, Andersson RE, et al
    Genetic Variants of the IL2 Gene Related to Risk and Survival in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:4933-4940.
    PubMed     Text format     Abstract available

  13. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Anticancer Res. 2019;39:5039-5045.
    PubMed     Text format     Abstract available


    BMC Cancer

  14. OTTAIANO A, Scala S, Normanno N, Napolitano M, et al
    Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
    BMC Cancer. 2019;19:899.
    PubMed     Text format     Abstract available


    Br J Cancer

  15. AL-SAFFAR NMS, Troy H, Wong Te Fong AC, Paravati R, et al
    Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma.
    Br J Cancer. 2018 Oct 31. pii: 10.1038/s41416-018-0242.
    PubMed     Text format     Abstract available


    Cancer

  16. RESNICK MJ, Graves AJ, Gambrel RJ, Thapa S, et al
    The association between medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
    Cancer. 2018 Nov 9. doi: 10.1002/cncr.31700.
    PubMed     Text format     Abstract available

  17. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    PubMed     Text format     Abstract available

  18. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
    Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
    PubMed     Text format     Abstract available


    Cancer Res

  19. PELULLO M, Nardozza F, Zema S, Quaranta R, et al
    Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains colorectal cancer progression and chemoresistance.
    Cancer Res. 2019 Sep 10. pii: 0008-5472.CAN-19-0145.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  20. YAEGER R, Kotani D, Mondaca S, Parikh AR, et al
    Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer.
    Clin Cancer Res. 2019 Sep 12. pii: 1078-0432.CCR-19-2004.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  21. LOKTIONOV A, Soubieres A, Bandaletova T, Mathur J, et al
    Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.
    Eur J Gastroenterol Hepatol. 2019;31:1220-1227.
    PubMed     Text format     Abstract available

  22. PASHA HF, Radwan MI, Yehia AM, Toam MM, et al
    Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Eur J Gastroenterol Hepatol. 2019 Sep 11. doi: 10.1097/MEG.0000000000001532.
    PubMed     Text format     Abstract available


    Gastroenterology

  23. DEY N, Kochman ML, Komanduri S, Melson JE, et al
    Report from the AGA Center for GI Innovation and Technology's Consensus Conference: Envisioning Next-Generation Paradigms in Colorectal Cancer Screening and Surveillance.
    Gastroenterology. 2019 Sep 13. pii: S0016-5085(19)41034.
    PubMed     Text format    


    Gastrointest Endosc

  24. CHU SJ, Kim JS, Kim BW
    Tubular adenoma overlying a colonic lipoma resected by endoscopic resection with use of a detachable endoloop.
    Gastrointest Endosc. 2019;89:894-895.
    PubMed     Text format    

  25. ZIMMER V, Eltze E
    Granulation polyp arising in a former device-assisted full-thickness resection site: Another kind of clip artifact?
    Gastrointest Endosc. 2019;89:893-894.
    PubMed     Text format    

  26. MATSUSHITA M, Takahashi Y, Wakamatsu T, Nishio A, et al
    Ideal submucosal injection solution for colorectal endoscopic submucosal dissection.
    Gastrointest Endosc. 2019;90:533.
    PubMed     Text format    

  27. REPICI A, Maselli R, Hassan C
    Response.
    Gastrointest Endosc. 2019;90:533-534.
    PubMed     Text format    

  28. SPADACCINI M, Hassan C, Maselli R, Repici A, et al
    Response.
    Gastrointest Endosc. 2019;90:536-537.
    PubMed     Text format    

  29. LI P, Ma B, Li W
    Underwater EMR for colorectal lesions.
    Gastrointest Endosc. 2019;90:536.
    PubMed     Text format    

  30. SCHMIDT A, Mueller J, Kuellmer A
    Response.
    Gastrointest Endosc. 2019;90:540.
    PubMed     Text format    

  31. ZHU H, Xu H
    Risk factors for early and late adenoma recurrence with regard to the histological margin.
    Gastrointest Endosc. 2019;90:541-542.
    PubMed     Text format    

  32. EMMANUEL A, Lapa C, Ghosh A, Gulati S, et al
    Response.
    Gastrointest Endosc. 2019;90:542.
    PubMed     Text format    

  33. TEHRANIAN S, Klinge M, Saul M, Morris M, et al
    Prevalence of Colorectal Cancer and Advanced Adenoma in Patients with Acute Diverticulitis: Implications for Follow-Up Colonoscopy.
    Gastrointest Endosc. 2019 Sep 12. pii: S0016-5107(19)32221.
    PubMed     Text format     Abstract available


    Int J Cancer

  34. GEIJSEN AJMR, van Roekel EH, van Duijnhoven FJB, Achaintre D, et al
    Plasma metabolites associated with colorectal cancer stage: findings from an international consortium.
    Int J Cancer. 2019 Sep 8. doi: 10.1002/ijc.32666.
    PubMed     Text format     Abstract available

  35. MIZUKOSHI K, Okazawa Y, Haeno H, Koyama Y, et al
    Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state.
    Int J Cancer. 2019 Sep 10. doi: 10.1002/ijc.32672.
    PubMed     Text format     Abstract available

  36. TIAN J, Ying P, Ke J, Zhu Y, et al
    ANKLE1 N(6) -Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability.
    Int J Cancer. 2019 Sep 11. doi: 10.1002/ijc.32677.
    PubMed     Text format     Abstract available

  37. TOMA C, Diaz-Gay M, Franch-Exposito S, Arnau-Collell C, et al
    Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer.
    Int J Cancer. 2019 Sep 16. doi: 10.1002/ijc.32683.
    PubMed     Text format     Abstract available

  38. DEOULA MS, El Kinany K, Huybrechts I, Gunter MJ, et al
    Consumption of meat, traditional and modern processed meat and colorectal cancer risk among the Moroccan population: A large-scale case-control study.
    Int J Cancer. 2019 Sep 16. doi: 10.1002/ijc.32689.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  39. DE FELICE F, Musio D, Tombolini V, Cortesi E, et al
    Commentary on: "Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12".
    Int J Colorectal Dis. 2019;34:1617-1618.
    PubMed     Text format    

  40. SODERBACK H, Gunnarsson U, Martling A, Hellman P, et al
    Incidence of wound dehiscence after colorectal cancer surgery: results from a national population-based register for colorectal cancer.
    Int J Colorectal Dis. 2019 Sep 9. pii: 10.1007/s00384-019-03390.
    PubMed     Text format     Abstract available

  41. CAO Y, Gu J, Deng S, Li J, et al
    Long-term tumour outcomes of self-expanding metal stents as 'bridge to surgery' for the treatment of colorectal cancer with malignant obstruction: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2019 Sep 12. pii: 10.1007/s00384-019-03372.
    PubMed     Text format     Abstract available


    J Am Coll Surg

  42. HUISKENS J, Bolhuis K, Engelbrecht MR, De Jong KP, et al
    Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
    J Am Coll Surg. 2019 Sep 11. pii: S1072-7515(19)32062.
    PubMed     Text format     Abstract available


    Oncol Rep

  43. TONG J, Shen Y, Chen X, Wang R, et al
    FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression.
    Oncol Rep. 2019 Aug 2. doi: 10.3892/or.2019.7259.
    PubMed     Text format     Abstract available

  44. GU J, Wang L, Li T, Tang S, et al
    Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo.
    Oncol Rep. 2019 Aug 7. doi: 10.3892/or.2019.7267.
    PubMed     Text format     Abstract available

  45. LI J, He J, Wang Y, Shu Y, et al
    SMC1 promotes proliferation and inhibits apoptosis through the NFkappaB signaling pathway in colorectal cancer.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7273.
    PubMed     Text format     Abstract available


    PLoS One


  46. Retraction: APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway.
    PLoS One. 2019;14:e0222525.
    PubMed     Text format    

  47. LU L, Zhuang T, Shao E, Liu Y, et al
    Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study.
    PLoS One. 2019;14:e0221964.
    PubMed     Text format     Abstract available

  48. LATHWAL A, Arora C, Raghava GPS
    Prediction of risk scores for colorectal cancer patients from the concentration of proteins involved in mitochondrial apoptotic pathway.
    PLoS One. 2019;14:e0217527.
    PubMed     Text format     Abstract available

  49. CHEN N, Kong Y, Wu Y, Gao Q, et al
    CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer.
    PLoS One. 2019;14:e0222035.
    PubMed     Text format     Abstract available


    World J Surg

  50. PEDZIWIATR M, Pisarska M, Ljungqvist O
    Authors' Reply: Compliance with the ERAS Protocol and 3-Year Survival After Laparoscopic Surgery for Nonmetastatic Colorectal Cancer.
    World J Surg. 2019 Sep 9. pii: 10.1007/s00268-019-05168.
    PubMed     Text format    

  51. KUAN TC, Chang SC, Lin JK, Lin TC, et al
    Prognosticators of Long-Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features.
    World J Surg. 2019 Sep 12. pii: 10.1007/s00268-019-05158.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: